Stephen Forman

Stephen J. Forman, MD, is a hematologist-oncologist, international expert in leukemia, lymphoma, and bone marrow transplant (BMT), and pioneer in immunotherapy. Dr. Forman has spent his 45-year career at City of Hope (COH), leading the Department of Hematology for 38 years and directing the Hematology Malignancies Research Institute since 2015. Under his leadership, COH developed one of the world’s largest and most successful BMT centers, which has led to dramatic increase in survival rates for blood cancers. He also directs the T cell Therapeutics Research Laboratories, the goal of which is to develop new ways to use the immune system to fight cancer. In this role, he leads a team of scientists in developing chimeric antigen receptor (CAR)-engineered T cells for treatment of a variety of cancers, including leukemia. Based on this research, Dr. Forman has led the advancement of multiple laboratory discoveries to the clinic, including CD19-directed CAR T cells for adults with leukemia.